A key part of our disruptive, patient-centred model of drug discovery is our collaborations with SMEs. We apply our expertise and resources to help reduce risk, share learnings, and improve success rates across early stage medicines R&D.
From your first engagement with us, we’ll work with you to understand the commercial and scientific potential of your projects and ideas. Our team can then identify the services and support you need.
We work with our partners in a range of different models:
Shared risk and reward
We routinely build consortia who work with us to address specific shared problems or to prove new techniques in multiple settings.
We work in risk-share collaborations with partners who gain from our unique help and where we share in the value of the outcome.
Joint grant applications for collaborative R&D funding
We identify funding opportunities for many of our collaborative projects. For non-dilutive funding we have specialist grant writing expertise to work with you in crafting top quality grant applications.
We also have a strong network of VC companies looking for new opportunities that we have helped to de-risk.
Contracted fee-for-service projects
Where you need managed access to our skills and assets – and cannot get them commercially elsewhere – we can adopt a fee-for-service model.
Signposting and connecting
We have a deep knowledge of the national landscape across public and private sectors, so we can help you find the right partner, collaborator, advisor or supplier who can deliver what you need.